157 filings
Page 6 of 8
8-K
klya53zz vy
6 Oct 17
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
avid2vu 0xqk
17 Aug 17
Entry into a Material Definitive Agreement
12:00am
8-K
h8czp 1aq8
14 Aug 17
Secures guarantee to fund company through 2018 with future rights offerings
12:00am
8-K
7h9iggvh9muepgbsa
10 Jul 17
Biostage Granted Continued Listing on Nasdaq
12:00am
8-K
rh3 r4g8e
27 Jun 17
Biostage Announces Agreement to Conduct $3.1 Million Private Placement at Market
12:00am
8-K
9o0 tsssdzktbvtva
22 May 17
Biostage Announces Receipt of Nasdaq Listing Determination
12:00am
8-K
c67fqjzcw9ie jsbw
11 May 17
Biostage Reports 2017 First Quarter Financial Results and Provides Business Update
12:00am
8-K
gzog1ekyn0qn
2 May 17
Regulation FD Disclosure
12:00am
8-K
ika0kbbrikyx6 yo0y
27 Apr 17
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
a00vcg44xv9omn4h16
6 Apr 17
Regulation FD Disclosure
12:00am
8-K
myl9fk
16 Mar 17
Departure of Directors or Certain Officers
12:00am
8-K
djnwheswwgobwa
10 Mar 17
Biostage Reports 2016 Financial Results and Provides Business Update
12:00am
8-K
0o8k194a3vjj43y86itk
22 Nov 16
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
3vqe3158vy9rw imw
10 Nov 16
Biostage Reports 2016 Third Quarter Financial Results and Provides Business Update
12:00am
8-K
cu4zh7
6 Oct 16
Biostage Provides Regulatory Update of Cellspan™ Esophageal Implant
12:00am
8-K
f9s99
12 Sep 16
Regulation FD Disclosure
12:00am
8-K
ow6l lthhint0yzl8t0
11 Aug 16
Biostage Reports 2016 Second Quarter Financial Results and Provides Business Update Outlining Key Near-term Milestones
12:00am
8-K
yjkva4 76y5a7
2 Jun 16
Regulation FD Disclosure
12:00am
8-K
x27 7kwebodpkj4a
26 May 16
Submission of Matters to a Vote of Security Holders
12:00am
8-K
nb2 42wvqqu
20 May 16
Entry into a Material Definitive Agreement
12:00am